Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Author, Hepatitis C Advocate, Health Educator
A look at exciting cancer research from the 2018 Conference on Retroviruses and Opportunistic Infections
The latest hepatitis C and HIV news from the annual Conference on Retroviruses and Opportunistic Infections (CROI).
Increased risk of death for people with hepatitis C who use alcohol, smoke cigarettes, use drugs , eat poorly, and don’t exercise.
The stigma attached to hepatitis C is more than painful; it can cause medical harm.
A look at the relationship between hepatitis C and cardiovascular disease.
In the U.S., acute hepatitis C infections aren’t usually treated. However, researchers analyzed this to see if it is the best practice.
Recently, studies showed that a common group of acid-reducing drugs may be contributing to unsuccessful hepatitis C treatment.
If your hepatitis was cured, but a new doctor tells you that you have hep C, should you panic? A look at what may be going on.
Hepatitis C reactivation may occur in people receiving cancer treatment. However, hep C reactivation may not mean what you think it does.
Beyond hepatitis A and C, taking a look at hepatitis B and D.
A recent study found that half of those cured of hepatitis C developed signs of non-alcoholic fatty liver disease (NAFLD). Are you at risk?
Taking a look back at the hepatitis C landscape over the past 20 years.
A hepatitis holiday message...
Hepatitis A outbreaks are occurring all over the world, including in the United States. However, hepatitis A can be easily prevented.
Hepatitis C virus infection is on the rise among women giving birth, putting a new generation at risk for infection.
Hepatitis C is curable, but it is not gone. Not by a long shot.
The facts about hepatitis C are offset by ignorance. This diver is trying to set the facts straight.
Liver cancer risk is higher if you have cirrhosis or late stage fibrosis, alcohol use, hepatitis B, and fatty liver disease.
When dealing with hepatitis C, our attitude can be an ally or an enemy.
Although the newest hepatitis C treatments are wonderful, they don’t fix everything. Are you at risk?
Highlights from the 2017 Liver Meeting, presented by the American Association for the Study of Liver Diseases.
Headlines from the 2017 Liver Meeting
Updated information about the most common liver disease in the United States, nonalcoholic fatty liver disease (NAFLD).
A look at the latest hepatitis C guidelines
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.